Ident. | Authors (with country if any) | Title |
---|
000029 |
Leigh Christopher [Canada] ; Connie Marras [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Robert Chen [Canada] ; Isabelle Boileau [Canada] ; Barbara Segura [Canada, Espagne] ; Oury Monchi [Canada] ; Anthony E. Lang [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment |
000059 |
JI HYUN KO [Canada] ; Francesca Antonelli [Canada] ; Oury Monchi [Canada] ; Nicola Ray [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Anthony E. Lang [Canada] ; Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Prefrontal Dopaminergic Receptor Abnormalities and Executive Functions in Parkinson's Disease |
000066 |
Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease |
000086 |
Scott Mackey [États-Unis, Canada] ; YU JING [République populaire de Chine, Canada] ; Joseph Flores [Suède, Canada] ; Katie Dinelle [Canada] ; Doris J. Doudet [Canada] | Direct intranigral administration of an ubiquitin proteasome system inhibitor in rat: Behavior, positron emission tomography, immunohistochemistry |
000114 |
Nicola J. Ray [Canada] ; Antonio P. Strafella [Canada] | The Neurobiology and Neural Circuitry of Cognitive Changes in Parkinson's Disease Revealed by Functional Neuroimaging |
000159 |
Per Borghammer [Danemark] ; S Ren B. Hansen [Danemark] ; Carsten Eggers [Allemagne] ; Mallar Chakravarty [Canada] ; KIM VANG [Danemark] ; Joel Aanerud [Danemark] ; Rüdiger Hilker [Allemagne] ; Wolf-Dieter Heiss [Allemagne] ; Anders Rodell [Danemark] ; Ole L. Munk [Danemark] ; David Keator [États-Unis] ; Albert Gjedde [Danemark] | Glucose metabolism in small subcortical structures in Parkinson's disease |
000176 |
Julia Sacher [Canada, Allemagne] ; Eugenii A. Rabiner [Canada] ; Michael Clark [Canada] ; Pablo Rusjan [Canada] ; Alexandra Soliman [Canada] ; Rada Boskovic [Canada] ; Stephen J. Kish [Canada] ; Alan A. Wilson [Canada] ; Sylvain Houle [Canada] ; Jeffrey H. Meyer [Canada] | Dynamic, adaptive changes in MAO-A binding after alterations in substrate availability: an in vivo [11C]-harmine positron emission tomography study |
000197 |
YILONG MA [États-Unis] ; SHUCHUN PENG [États-Unis] ; Phoebe G. Spetsieris [États-Unis] ; Vesna Sossi [Canada] ; David Eidelberg [États-Unis] ; Doris J. Doudet [Canada] | Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism |
000254 |
A. Jon Stoessl [Canada] ; David J. Brooks [Royaume-Uni] ; David Eidelberg [États-Unis] | Milestones in Neuroimaging |
000257 |
Ramachandiran Nandhagopal [Canada] ; Lisa Kuramoto [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jacqueline Cragg [Canada] ; Jess Mckenzie [Canada] ; Siobhan Mccormick [Canada] ; Thomas J. Ruth [Canada] ; Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; A. Jon Stoessl [Canada] | Longitudinal evolution of compensatory changes in striatal dopamine processing in Parkinson's disease |
000304 |
Sandra E. Leh [Canada] ; Michael Petrides [Canada] ; Antonio P. Strafella [Canada] | The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease |
000373 |
Stephen J. Kish [Canada] ; Jason Lerch [Canada] ; Yoshiaki Furukawa [Canada, Japon] ; Junchao Ton [Canada] ; Tina Mccluskey [Canada] ; Diana Wilkins [États-Unis] ; Sylvain Houle [Canada] ; Jeffrey Meyer [Canada] ; Emanuela Mundo [Italie] ; Alan A. Wilson [Canada] ; Pablo M. Rusjan [Canada] ; Jean A. Saint-Cyr [Canada] ; Mark Guttman [Canada] ; D. Louis Collins [Canada] ; Colin Shapiro [Canada] ; Jerry J. Warsh [Canada] ; Isabelle Boileau [Canada] | Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study |
000425 |
Benedicte Ballanger [Canada, France] ; Marjan Jahanshahi [Royaume-Uni] ; Emmanuel Broussolle [France] ; Stéphane Thobois [France] | PET functional imaging of deep brain stimulation in movement disorders and psychiatry |
000426 |
A. R. Troiano [Canada] ; R. De La Fuente-Fernandez [Canada] ; V. Sossi [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; T. J. Ruth [Canada] ; A. J. Stoessl [Canada] | PET demonstrates reduced dopamine transporter expression in PD with dyskinesias |
000443 |
R. Nandhagopal [Canada] ; L. Kuramoto [Canada] ; M. Schulzer [Canada] ; E. Mak [Canada] ; J. Cragg [Canada] ; Chong S. Lee [Canada] ; J. Mckenzie [Canada] ; S. Mccormick [Canada] ; A. Samii [États-Unis] ; A. Troiano [Canada] ; T. J. Ruth [Canada] ; V. Sossi [Canada] ; R. De La Fuente-Fernandez [Canada] ; Donald B. Caine [Canada] ; A. J. Stoessl [Canada] | Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study |
000454 |
T. D. L. Steeves [Canada] ; J. Miyasaki [Canada] ; M. Zurowski [Canada] ; A. E. Lang [Canada] ; G. Pellecchia [Canada] ; T. Van Eimeren [Canada] ; P. Rusjan [Canada] ; S. Houle [Canada] ; A. P. Strafella [Canada] | Increased striatal dopamine release in Parkinsonian patients with pathological gambling : a [11C] raclopride PET study |
000469 |
Stuart W. S. Macdonald [Canada, Suède] ; Simon Cervenka [Suède] ; Lars Farde [Suède] ; Lars Nyberg [Suède] ; Lars B Ckman [Suède] | Extrastriatal dopamine D2 receptor binding modulates intraindividual variability in episodic recognition and executive functioning |
000478 |
Vesna Sossi [Canada] ; Katherine Dinelle [Canada] ; Geoffrey J. Topping [Canada] ; James E. Holden [États-Unis] ; Doris Doudet [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Raul De La Fuente-Femandez [Canada] | Dopamine transporter relation to levodopa-derived synaptic dopamine in a rat model of Parkinson's : an in vivo imaging study |
000482 |
Isabelle Boileau [Canada] ; Mark Guttman [Canada] ; Pablo Rusjan [Canada] ; John R. Adams [Canada] ; Sylvain Houle [Canada] ; JUNCHAO TONG [Canada] ; Oleh Hornykiewicz [Autriche] ; Yoshiaki Furukawa [Canada] ; Alan A. Wilson [Canada] ; Shitij Kapur [Canada] ; Stephen J. Kish [Canada] | Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naïve Parkinson's disease |
000488 |
Benedicte Ballanger [Canada] ; Andres M. Lozano [Canada] ; Elena Moro [Canada] ; Thilo Van Eimeren [Canada] ; Clement Hamani [Canada] ; Robert Chen [Canada] ; Roberto Cilia [Canada] ; Sylvain Houle [Canada] ; YU YAN POON [Canada] ; Anthony E. Lang [Canada] ; Antonio P. Strafella [Canada] | Cerebral Blood Flow Changes Induced by Pedunculopontine Nucleus Stimulation in Patients With Advanced Parkinson's Disease: A [15O] H2O PET Study |
000502 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Benedicte Ballanger [Canada] ; Yu-Yan Poon [Canada] ; Anthony E. Lang [Canada] ; Elena Moro [Canada] | rCBF Changes Associated with PPN Stimulation in a Patient with Parkinson's disease : A PET Study |
000511 |
Karin A. Stephenson [Canada] ; Erik M. Van Oosten [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Sylvain Houle [Canada] ; Neil Vasdev [Canada] | Synthesis and preliminary evaluation of [18F]-fluoro-(2S)-Exaprolol for imaging cerebral β-adrenergic receptors with PET |
000520 |
R. Nandhagopal [Canada] ; E. Mak [Canada] ; M. Schulzer [Canada] ; J. Mckenzie [Canada] ; S. Mccormick [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; A. Strongosky [États-Unis] ; M. J. Farrer [États-Unis] ; Z. K. Wszolek [États-Unis] ; A. J. Stoessl [Canada] | Progression of dopaminergic dysfunction in a LRRK2 kindred : A multitracer PET study |
000529 |
M. H. Beauchamp [Canada] ; A. Dagher [Canada] ; M. Panisset [Canada] ; J. Doyon [Canada] | Neural substrates of cognitive skill learning in Parkinson's disease |
000550 |
Isabelle Boileau [Canada] ; Jerry J. Warsh [Canada] ; Mark Guttman [Canada] ; Jean A. Saint-Cyr [Canada] ; Tina Mccluskey [Canada] ; Pablo Rusjan [Canada] ; Sylvain Houle [Canada] ; Alan A. Wilson [Canada] ; Jeffrey H. Meyer [Canada] ; Stephen J. Kish [Canada] | Elevated Serotonin Transporter Binding in Depressed Patients with Parkinson's Disease : A Preliminary PET Study with [11C]DASB |
000556 |
W. R. Wayne Martin [Canada] ; Marguerite Wieler [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] | Dihydrotetrabenazine Positron Emission Tomography Imaging in Early, Untreated Parkinson's Disease |
000598 |
Antonio P. Strafella [Canada] ; Andres M. Lozano [Canada] ; Anthony E. Lang [Canada] ; JI HYUN KO [Canada] ; Yu-Yan Poon [Canada] ; Elena Moro [Canada] | Subdural Motor Cortex Stimulation in Parkinson's Disease Does Not Modify Movement-Related rCBF Pattern |
000658 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Espagne] ; Michael Schulzer [Canada] ; Andre R. Troiano [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Dopamine Transporter Relation to Dopamine Turnover in Parkinson's Disease : A Positron Emission Tomography Study |
000712 |
Kaveh M. Koochesfahani [Canada] ; Raul De La Fuente-Fernandez [Canada, Espagne] ; Vesna Sossi [Canada] ; Michael Schulzer [Canada] ; Lakshmi N. Yatham [Canada] ; Thomas J. Ruth [Canada] ; Stephan Blinder [Canada] ; A. Jon Stoessl [Canada] | Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients : Positron emission tomographic studies |
000775 |
WING LOK AU [Canada] ; John R. Adams [Canada] ; André R. Troiano [Canada] ; A. Jon Stoessl [Canada] | Parkinson's disease : in vivo assessment of disease progression using positron emission tomography |
000777 |
John R. Adams [Canada] ; Hinke Van Netten [Canada] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Jessamyn Mckenzie [Canada] ; Audrey Strongosky [États-Unis] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; Chong S. Lee [Canada] ; Matthew Farrer [États-Unis] ; Thomas Gasser [Allemagne] ; Ryan J. Uitti [États-Unis] ; Donald B. Calne [Canada] ; Zbigniew K. Wszolek [États-Unis] ; A. Jon Stoessl [Canada] | PET in LRRK2 mutations : comparison to sporadic parkinson's disease and evidence for presymptomatic compensation |
000861 |
D. J. Doudet [Canada] ; M. L. Cornfeldt [États-Unis] ; C. R. Honey [Canada] ; A. W. Schweikert [États-Unis] ; R. C. Allen [États-Unis] | PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of parkinson's disease |
000868 |
Raul De La Fuente-Fernandez [Canada] ; Vesna Sossi [Canada] ; ZHIGAO HUANG [Canada] ; Sarah Furtado [Canada] ; Jian-Qiang Lu [Canada] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson's disease: implications for dyskinesias |
000870 |
Y. Kumakura [Danemark] ; E. H. Danielsen [Danemark] ; A. Reilhac [Canada] ; A. Gjedde [Danemark, Canada] ; P. Cumming [Danemark] | Levodopa effect on [18F]fluorodopa influx to brain: normal volunteers and patients with Parkinson's disease |
000893 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; James E. Holden [Canada] ; Michael Schulzer [Canada] ; Thomas J. Ruth [États-Unis] ; Jon Stoessl [Canada] | Changes of dopamine turnover in the progression of Parkinson's disease as measured by positron emission tomography: Their relation to disease-compensatory mechanisms |
000903 |
Ajit Kumar [Canada] ; Sharanpal Mann [Canada] ; Vesna Sossi [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] ; Michael Schulzer [Canada] ; Chong S. Lee [Canada] | [11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease |
000914 |
Antonio P. Strafella [Canada] ; Tomas Paus [Canada] ; Maria Fraraccio [Canada] ; Alain Dagher [Canada] | Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex |
000915 |
Aviva Abosch [Canada] ; Shitij Kapur [Canada] ; Anthony E. Lang [Canada] ; Doug Hussey [Canada] ; Elspeth Sime [Canada] ; Janis Miyasaki [Canada] ; Svlvain Houle [Canada] ; Andres M. Lozano [Canada] ; Philip Starr ; Giovanni Broggi ; Roy A. E. Bakay ; Nicholas Boulis ; Ali R. Rezai | Stimulation of the subthalamic nucleus in Parkinson's disease does not produce striatal dopamine release. Commentary |
000917 |
Alan L. Whone [Royaume-Uni] ; Ray L. Watts [États-Unis] ; A. Jon Stoessl [Canada] ; Margaret Davis [États-Unis] ; Sven Reske [Allemagne] ; Claude Nahmias [Canada] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Maria J. Ribeiro [France] ; Philippe Remy [France] ; Werner Poewe [Autriche] ; Robert A. Hauser [États-Unis] ; David J. Brooks [Royaume-Uni] | Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study |
000968 |
G. V. Mcdonnell [Canada] ; J. Cabrera-Gomez [Canada] ; D. B. Calne [Canada] ; D. K. B. Li [Canada] ; J. Oger [Canada] | Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: The subclinical stage of primary progressive multiple sclerosis may last 10 years |
000991 |
Ivar Mendez [Canada] ; Alain Dagher ; Murray Hong ; Paula Gaudet ; Swarna Weerasinghe ; Vivian Mcalister ; David King ; Jacques Desrosiers ; Sultan Darvesh ; Tanya Acorn ; Harold Robertson | Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study: Report of three cases |
000A14 |
Vesna Sossi [Canada] ; Raul De La Fuente-Fernandez [Canada] ; James E. Holden [États-Unis] ; Doris J. Doudet [Canada] ; Jess Mckenzie [Canada] ; A. J. Stoessl [Canada] ; T. J. Ruth [Canada] | Increase in dopamine turnover occurs early in Parkinson's disease: Evidence from a new modeling approach to PET 18F-fluorodopa data |
000A36 |
Yun J. Kim [Canada] ; Masanori Ichise [Canada] ; James R. Ballinger [Canada] ; Douglas Vines [Canada] ; Sean S. Erami [Canada] ; Tatsuro Tatschida [Canada] ; Anthony E. Lang [Canada] | Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP |
000A52 |
Alain Dagher [Royaume-Uni, Canada] ; Adrian M. Owen [Royaume-Uni] ; Henning Boecker [Royaume-Uni] ; David J. Brooks [Royaume-Uni] | The role of the striatum and hippocampus in planning : A PET activation study in Parkinson's disease |
000A64 |
Vijay Dhawan [États-Unis] ; David Eidelberg [États-Unis] | SPECT imaging in Parkinson's disease |
000A71 |
Doris J. Doudet [Canada] | PET studies in the MPTP model of Parkinson's disease |
000A73 |
A. Jon Stoessl [Canada] | Neurochemical and neuroreceptor imaging with PET in Parkinson's disease |
000A76 |
M. Fukuda [États-Unis] ; M. J. Mentis [États-Unis] ; Y. Ma [États-Unis] ; V. Dhawan [États-Unis] ; A. Antonini [États-Unis] ; A. E. Lang [Canada] ; A. M. Lozano [Canada] ; J. Hammerstad [États-Unis] ; K. Lyons [États-Unis] ; W. C. Koller [États-Unis] ; J. R. Moeller [États-Unis] ; D. Eidelberg [États-Unis] | Networks mediating the clinical effects of pallidal brain stimulation for Parkinson's disease: A pet study of resting-state glucose metabolism |
000A78 |
Doris J. Doudet [Canada] | Monitoring disease progression in Parkinson's disease |
000A87 |
M. Guttman [Canada] ; D. Stewart [Canada] ; D. Hussey [Canada] ; A. Wilson [Canada] ; S. Houle [Canada] ; S. Kish [Canada] | Influence of L-dopa and pramipexole on striatal dopamine transporter in early PD |
000B01 |
Masafumi Fukuda [États-Unis] ; Marc Mentis [États-Unis] ; Maria Felice Ghilardi [États-Unis] ; Vijay Dhawan [États-Unis] ; Angelo Antonini [États-Unis] ; John Hammerstad [États-Unis] ; Andres M. Lozano [Canada] ; Anthony Lang [Canada] ; Kelly Lyons [États-Unis] ; William Koller [États-Unis] ; Claude Ghez [États-Unis] ; David Eidelberg [États-Unis] | Functional correlates of pallidal stimulation for Parkinson's Disease |
000B32 |
Raul De La Fuente-Fernandez [Canada] ; Jian-Qiang Lu [Canada] ; Vesna Sossi [Canada] ; Salma Jivan [Canada] ; Michael Schulzer [Canada] ; James E. Holden [États-Unis] ; Chong S. Lee [Canada] ; Thomas J. Ruth [Canada] ; Donald B. Calne [Canada] ; A. Jon Stoessl [Canada] | Biochemical variations in the synaptic level of dopamine precede motor fluctuations in Parkinson's disease : PET evidence of increased dopamine turnover |
000B34 |
Raul De La Fuente-Fernandez [Canada] ; Andrew S. Lim [Canada] ; Vesna Sossi [Canada] ; James E. Holden [États-Unis] ; Donald B. Calne [Canada] ; Thomas J. Ruth [Canada] ; A. Jon Stoessl [Canada] | Apomorphine-induced changes in synaptic dopamine levels : Positron emission tomography evidence for presynaptic inhibition |
000B66 |
B. J. Snow [Canada] ; F. J. G. Vingerhoets [Canada] ; J. W. Langston [États-Unis] ; J. W. Tetrud [États-Unis] ; V. Sossi [Canada] ; D. B. Calne [Canada] | Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism |
000B71 |
R. De La Fuente-Fernandez [Canada] ; A. Kishore [Canada] ; D. B. Calne [Canada] ; T. J. Ruth [Canada] ; A. J. Stoessl [Canada] | Nigrostriatal dopamine system and motor lateralization |
000B88 |
C. S. Lee [Canada] ; A. Samii [Canada] ; V. Sossi [Canada] ; T. J. Ruth [Canada] ; M. Schulzer [Canada] ; J. E. Holden [États-Unis] ; J. Wudel [Canada] ; P. K. Pal [Canada] ; R. De La Fuente-Fernandez [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson's disease |
000B92 |
R. De La Fuente-Fernandez [Canada] ; P. K. Pal [Canada] ; F. J. G. Vingerhoets [Canada] ; A. Kishore [Canada] ; M. Schulzer [Canada] ; E. K. Mak [Canada] ; T. J. Ruth [Canada] ; B. J. Snow [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | Evidence for impaired presynaptic dopamine function in parkinsonian patients with motor fluctuations |
000C14 |
H. Barthel [Allemagne] ; U. Müller [Allemagne] ; T. W Chter [Allemagne] ; P. Slomka [Canada] ; C. Dannenberg [Allemagne] ; T. Murai [Allemagne] ; T. Kahn [Allemagne] ; P. Georgi [Allemagne] | Multimodale SPECT- und MRT-Bilddatenanalyse zur Verbesserung der Diagnostik des idiopathischen Parkinson-Syndroms : Radiologische Diagnostik und Nuklearmedizin |
000C27 |
M. Ichise [Canada] ; Y. J. Kim [Canada] ; J. R. Ballinger [Canada] ; D. Vines [Canada] ; S. S. Erami [Canada] ; F. Tanaka [Canada] ; A. E. Lang [Canada] | SPECT imaging of pre- and postsynaptic dopaminergic alterations in L-dopa-untreated PD |
000C32 |
Nicolaas Paul L. G. Verhoeff [Canada] | Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders |
000C35 |
J. B. A. Habraken [Pays-Bas, Canada] ; J. Booij ; P. Slomka ; E. B. Sokole ; E. A. Van Royen | Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm |
000C40 |
A. Samii [Canada] ; K. Markopoulou [États-Unis] ; Z. K. Wszolek [États-Unis] ; V. Sossi [Canada] ; T. Dobko [Canada] ; E. Mak [Canada] ; D. B. Calne [Canada] ; A. J. Stoessl [Canada] | PET studies of parkinsonism associated with mutation in the α-synuclein gene |
000C48 |
R. A. Hauser [États-Unis] ; T. B. Freeman [États-Unis] ; B. J. Snow [Canada] ; M. Nauert [États-Unis] ; L. Gauger [États-Unis] ; J. H. Kordower [États-Unis] ; C. W. Olanow [États-Unis] | Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease |
000D30 |
A. M. Owen [Royaume-Uni] ; J. Doyon [Canada] ; A. Dagher [Canada] ; A. Sadikot [Canada] ; A. C. Evans [Canada] | Abnormal basal ganglia outflow in Parkinson's disease identified with PET : Disease identified with pet implications for higher cortical functions |
000D43 |
O. Rascol [France] ; N. Fabre [France] ; U. Sabatini [Italie] | Imagerie fonctionnelle |
000D48 |
M. Guttman [Canada] ; J. Burkholder [États-Unis] ; S. J. Kish [Canada] ; D. Hussey [États-Unis] ; A. Wilson [États-Unis] ; J. Dasilva [États-Unis] ; S. Houle [États-Unis] | [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson's disease : Implications for the symptomatic threshold |
000D49 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer [Canada] ; D. B. Calne [Canada] ; B. J. Snow [Canada] | Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? |
000E12 |
F. J. G. Vingerhoets [Canada] ; M. Schulzer ; T. J. Ruth ; J. E. Holden ; B. J. Snow | Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-dopa PET in Parkinson's disease |
000E17 |
L. Wahl [Canada] ; C. Nahmias [Canada] | Modeling of fluorine-18-6-fluoro-L-Dopa in humans |
000E46 |
H. Shinotoh [Canada] ; D. B. Calne | The use of PET in Parkinson's disease |
000E52 |
H. Kuwabara [Canada] ; P. Cumming ; Y. Yasuhara ; G. C. Leger ; M. Guttman ; M. Diksic ; A. C. Evans ; A. Gjedde | Regional striatal DOPA transport and decarboxylase activity in Parkinson's disease |
000E79 |
C. Nahmias [Canada] ; L. Wahl ; R. Chirakal ; G. Firnau ; E. S. Garnett | A probe for intracerebral aromatic amino-acid decarboxylase activity : distribution and kinetics of [18F]6-fluoro-L-m-tyrosine in the human brain |
000E99 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow [Canada] ; J. W. Tetrud ; J. W. Langston ; M. Schulzer [Canada] ; D. B. Calne [Canada] | Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions |
000F06 |
F. J. G. Vingerhoets [Canada] ; B. J. Snow ; C. S. Lee ; M. Schulzer ; E. Mak ; D. B. Calne | Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic Parkinsonism |
000F39 |
B. J. Snow [Canada] ; I. Tooyama ; E. G. Mcgeer [Canada] ; T. Yamada ; D. B. Calne [Canada] ; H. Takahashi [Canada] ; H. Kimura | Human positron emission tomographic [18F]fluorodopa studies correlate with dopamine cell counts and levels |
000F46 |
B. D. Pate [Canada] ; T. Kawamata ; T. Yamada ; E. G. Mcgeer [Canada] ; K. A. Hewitt [Canada] ; B. J. Snow [Canada] ; T. J. Ruth [Canada] ; D. B. Calne [Canada] | Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices |
000F60 |
H. Hoshi [Canada] ; H. Kuwabara ; G. Leger ; P. Cumming ; M. Guttman ; A. Gjedde | 6-[18F]fluoro-L-DOPA metabolism in living human brain : a comparison of six analytical methods |
000F77 |
G. L.-Y. Chan [Canada] ; K. Scott Morrison ; J. E. Holden ; T. J. Ruth | Plasma L-[18F]6-Fluorodopa input function : a simplified method |
001000 |
R. F. Peppard [Canada] ; R. Wayne Martin [Canada] ; G. D. Carr ; E. Grochowski ; M. Schulzer [Canada] ; M. Guttman [Canada] ; P. L. Mcgeer ; A. G. Phillips ; J. K. C. Tsui [Canada] ; D. B. Calne [Canada] | Cerebral glucose metabolism in Parkinson's disease with and without dementia |
001010 |
M. Cordes [Canada] ; B. J. Snow ; H. Takahashi ; P. Schofield ; S. Cooper ; V. Sossi ; S. Morrison ; D. B. Calne | L-18F-DOPA-PET bei Parkinson-Plus-Syndromen zum Nachweis einer gestörten präsynaptischen dopaminergen Funktion |
001017 |
M. H. Bhatt ; B. J. Snow ; W. R. Wayne Martin ; B. D. Pate ; D. B. Calne | Positron emission tomography suggests that the rate of progression of idiopthic parkinsonism is slow |
001050 |
M. H. Bhatt ; B. J. Snow ; W. R. W. Martin ; S. Cooper ; D. B. Calne | Positron emission tomography in Shy-Drager syndrome |
001051 |
B. J. Snow ; R. F. Peppard ; M. Guttman ; J. Okada ; W. Martin ; J. Steele ; A. Eisen ; G. Carr ; B. Schoenberg ; D. Calne | Positron emission tomographic scanning demonstrates a presynaptic dopaminergic lesion in lytico-bodig : the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of guam |
001072 |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in Parkinson's and Alzheimer's disease |
001087 |
E. C. Wolters ; C.-C. Huang ; C. Clark ; R. F. Peppard ; J. Okada ; N.-S. Chu ; M. J. Adam ; T. J. Ruth ; D. Li ; D. B. Calne | Positron emission tomography in manganese intoxication |
001090 |
M. Guttman ; R. S. Burns ; W. R. W. Martin ; R. F. Peppard ; M. J. Adam ; T. J. Ruth ; G. Allen ; R. A. Parker ; N. B. Tulipan ; D. B. Calne | PET studies of Parkinsonian patients treated with autologous adrenal implants |
001186 |
W. R. W. Martin | Positron emission tomography in movement disorders |